| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.032 | 0.8 |